This innovative project represents a cutting-edge integration of patient-centered electronic health monitoring tools directly embedded within EPIC, one of the most widely used electronic health record (EHR) systems. By leveraging electronic patient-reported outcomes (ePROs), the initiative aims to systematically capture, track, and respond to symptom severity and fluctuations as reported directly by patients undergoing cancer therapy. The seamless integration into EPIC facilitates immediate access to critical patient data by clinical teams, enabling more timely and personalized interventions to manage symptoms effectively.

Leading this transformative effort are Dr. Peter Pronovost, MD, PhD, Chief Quality and Clinical Transformation Officer at University Hospitals and Veale Distinguished Chair in Leadership and Clinical Transformation, alongside Dr. Melinda Hsu, MD, a prominent medical oncologist at UH Seidman Cancer Center. Their leadership underscores a strategic commitment to embedding evidence-based, patient-centered care models within complex healthcare systems, aiming to revolutionize cancer symptom management through technological innovation and rigorous clinical science.

The scope of the project encompasses ten clinical locations, including the flagship UH Cleveland Medical Center, targeting a high volume of patients—over 10,000 individuals across Northeast Ohio alone. This scale not only reflects the ambition to drive widespread clinical impact but also serves as a critical testing ground for developing scalable, sustainable models of digital symptom monitoring that could be disseminated nationally and beyond.

The conceptual foundation for this initiative derives from prior PCORI-funded comparative clinical effectiveness research, which demonstrated that patients actively completing electronic patient-reported outcome surveys reported significantly enhanced symptom control, improved physical function, and better overall health-related quality of life when compared to traditional care approaches. These data underscore the transformative potential of ePROs to shift the paradigm in oncology symptom management from reactive to proactive care.

The project’s electronic monitoring tools are designed to capture granular patient data across multiple symptom domains in a systematic and user-friendly manner. This empowers clinicians to identify emerging symptom patterns earlier, adjust therapeutic regimens more precisely, and provide supportive care interventions tailored to evolving patient needs. The use of real-time symptom data also supports shared decision-making by facilitating transparent communication among patients, caregivers, and multidisciplinary care teams.

Moreover, this initiative aligns with the objectives of PCORI’s Health Systems Implementation Initiative (HSII), which aims to bridge the persistent 17-year gap often observed between evidence generation and clinical application. By involving health system stakeholders directly in the design, implementation, and refinement of these digital tools, the project embodies a pragmatic approach to knowledge translation that prioritizes real-world applicability and sustainability in complex health settings.

The successful integration of ePROs into existing EHR infrastructure such as EPIC is itself a remarkable technical achievement. It leverages health informatics expertise to ensure interoperability, data security, and workflow integration, minimizing clinician burden while maximizing the utility of patient-generated data. This represents a model for how health systems can adopt next-generation digital health innovations within established clinical frameworks without disruption.

Another notable aspect is the multidisciplinary nature of the project team, which includes oncologists, quality improvement specialists, informatics experts, and patient advocates. This collaborative approach ensures that the technology and clinical pathways developed remain patient-centered, clinically valid, and operationally feasible across the diverse settings of the UH Seidman Cancer Center network.

The anticipated outcomes extend beyond immediate symptom management. By improving symptom control and patient engagement, the project aspires to enhance therapeutic adherence, reduce avoidable emergency department visits and hospitalizations, and ultimately improve survival outcomes. These multidimensional benefits reinforce the critical importance of integrating patient voice directly into the fabric of cancer care delivery.

As the project moves forward, ongoing evaluation and iteration will be essential. Continuous data analysis will help identify best practices, uncover potential disparities in symptom reporting or care responsiveness, and refine algorithms that trigger clinical alerts based on symptom severity thresholds. This iterative process reflects a learning health system model, where data drives continuous quality improvement.

In the broader context of oncology and chronic disease management, this initiative exemplifies the shift toward precision medicine paradigms that include not only molecular and genetic precision but also precision in supportive care through digital health. By embracing ePROs and integrating them within routine clinical workflows, University Hospitals Seidman Cancer Center is positioning itself at the forefront of a healthcare revolution that prioritizes patient experience as an essential outcome metric.

Finally, this funding award by PCORI, pending contractual finalization, represents both a validation of the clinical importance of symptom management and a strategic investment in transforming cancer care infrastructure using digital health technologies. It is anticipated that the knowledge and methodologies developed through this work will catalyze broader adoption across health systems nationally, ultimately benefiting the millions of patients undergoing cancer treatment worldwide.

Subject of Research: Electronic patient-reported outcomes monitoring to improve symptom management in cancer patients
Article Title: University Hospitals Seidman Cancer Center Advances Cancer Symptom Management Through Integrated Electronic Patient-Reported Outcome Tools
News Publication Date: Not specified
Web References:
– PCORI study on electronic patient-reported outcomes: https://www.pcori.org/research-results/2023/using-electronic-patient-reported-outcomes-epros-monitor-symptoms-during-cancer-treatment
– PCORI Health Systems Implementation Initiative: https://www.pcori.org/implementation-evidence/putting-evidence-work/health-systems-implementation-initiative
References: Not explicitly included in the original content
Image Credits: Not provided
Keywords: Diseases and disorders, Health care

The implementation of Varian Ethos 2.0 comes after extensive strategic planning and collaboration among the leadership at University Hospitals and the dedicated radiation oncology team. The technology offers rapid diagnostic-quality image guidance, allowing oncologists to deliver radiation treatment that is both minimally invasive and remarkably effective. In fact, it is now possible to potentially eradicate cancer in as few as a single treatment session, fundamentally changing patient outcomes and experiences in cancer therapy.

Traditionally, radiation treatment has faced challenges due to the dynamic nature of tumors and healthy organs, which can alter shape and position during the course of therapy. Factors such as the movement of the stomach, bowel, or bladder can complicate the delivery of a pre-planned dose of radiation. Standard technologies often prioritize caution over aggression to avoid harming surrounding healthy tissues, leading to potentially less effective treatment outcomes.

With the advent of adaptive radiotherapy, however, healthcare providers can now deliver radiation with enhanced accuracy on a daily basis, effectively accommodating the anatomical changes that occur over time. This capability ensures that patients receive a targeted dose of radiation each day, significantly improving the precision of treatment and minimizing the risk of collateral damage to healthy tissues. Such advanced methodologies not only enhance the efficacy of cancer treatments but also contribute to a more patient-centric approach in oncology.

The adaptive treatment planning facilitated by Varian Ethos 2.0 allows for adjustments to be made based on the exact anatomical situation on the day of treatment. Artificial Intelligence plays a vital role in bolstering the accuracy and efficiency of this process, enabling a collaborative effort among physicians, medical physicists, and radiation therapists. For example, if a treatment session is conducted after a patient has eaten, the system will adjust for any displacement of tumors as well as variations in the bowel as digestion occurs, thereby ensuring maximum safety for the small and large intestines.

Upon evaluating the original and adaptive plans, care teams always aim for the optimal route. The adaptive plans frequently emerge as the superior choice, allowing for tailored treatments that significantly enhance the likelihood of success. This continuous improvement process aligns with the goals of many healthcare institutions to prioritize patient welfare and provide state-of-the-art medical solutions in the fight against cancer.

Dr. Daniel Spratt, the Chair of Radiation Oncology at UH Cleveland Medical Center, emphasizes the implications of the Varian Ethos 2.0 technology in terms of patient impact. Under the guidance of a distinguished leadership team involving Dr. Lauren Henke, Director of GI Radiation Oncology, Dr. Alex Price, Lead Adaptive Physicist, and Dr. Rojano Kashani, Chief of Physics and Dosimetry, the center has successfully treated complex cases, including numerous patients diagnosed with pancreatic cancer. This collaborative effort underscores the team’s commitment to pioneering effective solutions in cancer treatment.

Moreover, the adaptive capabilities of this technology have also been demonstrated in treating kidney cancer, as illustrated by Dr. Angela Jia, Director of GU Radiation Oncology. In her recent case, a patient with kidney cancer located near the intestine received a single session of adaptive radiosurgery, achieving a successful outcome while ensuring safety from potential adverse effects. Such cases exemplify the exceptional potential of adaptive radiotherapy in managing complicated cancer scenarios.

The applications of Varian Ethos 2.0 are extensive, spanning a wide array of cancer types found throughout the body. This includes, but is not limited to, prostate, lung, breast, pancreatic, liver, head and neck, bladder, gynecologic, and anal cancers. The breadth of effectiveness this system offers holds great promise for improving the lives of countless patients battling these diverse and challenging conditions.

As researchers and medical practitioners continue to investigate the benefits of this technology, the prospect of integrating adaptive radiotherapy into routine clinical practice becomes increasingly likely. The continuous development and refinement of treatment modalities like the Varian Ethos 2.0 play a crucial role in enhancing overall survival rates and quality of life for cancer patients in an ever-evolving field of oncology.

In conclusion, the introduction of Varian Ethos 2.0 represents a significant leap forward in the treatment of cancer. The ability to customize and adjust treatment plans daily signifies not only a technical achievement but also a profound commitment to the well-being of patients. As University Hospitals Seidman Cancer Center leads the charge in employing such revolutionary technologies, the future of cancer care appears more promising than ever before.

The journey of enhancing cancer treatment through advanced technologies like adaptive radiotherapy continues to evolve, and the commitment of dedicated medical professionals ensures that patient care remains at the forefront of these innovations. As research progresses and technology advances, we can expect to witness even greater strides in the battle against cancer, prompting hope for patients and their families worldwide.

Subject of Research: Adaptive Radiotherapy
Article Title: Pioneering Adaptive Radiotherapy at University Hospitals Seidman Cancer Center: A New Era in Cancer Treatment
News Publication Date: [Insert Date]
Web References: [Insert Relevant URLs]
References: [Insert Relevant Academic References]
Image Credits: Credit: University Hospitals Seidman Cancer Center

Keywords: Radiation therapy, Adaptive radiotherapy, Cancer treatment, Oncology, Varian Ethos 2.0, Personalized medicine, Cleveland medical innovations.